According to Titan Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $0 M. In 2022 the company made a revenue of $0.06 M a decrease over the years 2021 revenue that were of $1.3 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0 M | -98.36% |
2022 | $0.06 M | -95.31% |
2021 | $1.3 M | -70.74% |
2020 | $4.45 M | 23.23% |
2019 | $3.61 M | -38.92% |
2018 | $5.91 M | 2649.77% |
2017 | $0.21 M | -98.57% |
2016 | $15.06 M | 801.56% |
2015 | $1.67 M | -54.16% |
2014 | $3.64 M | -65.22% |
2013 | $10.48 M | 47.27% |
2012 | $7.11 M | 74.95% |
2011 | $4.06 M | -59.69% |
2010 | $10.09 M | 12675.95% |
2009 | $0.07 M | |
2006 | $0.03 M | -64.04% |
2005 | $0.08 M | |
2002 | $2.89 M | -36.75% |
2001 | $4.57 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 9,302,199,900.00% | ๐บ๐ธ USA |
Novartis NVS | $49.92 B | 4,992,399,900.00% | ๐จ๐ญ Switzerland |
Vanda Pharmaceuticals VNDA | $0.19 B | 19,263,900.00% | ๐บ๐ธ USA |
Repligen
RGEN | $0.63 B | 63,876,300.00% | ๐บ๐ธ USA |
MediciNova MNOV | $1 M | 99,900.00% | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $6.88 M | 688,200.00% | ๐บ๐ธ USA |